NCT00189618View on ClinicalTrials.gov

The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

June 30, 2008

Conditions
Peripheral Arterial Disease
Interventions
DRUG

Aspirin

100mg p.o. OD

DRUG

Clopidogrel

75mg p.o. OD

Trial Locations (16)

1011

University Hospital LAusanne, Lausanne

4031

University Hospital Basel Dpt. Angiology, Basel

4101

Kantonsspital Bruderholz, Bruderholz

4410

Kantonsspital Liestal, Liestal

6000

Kantonsspital Luzern, Lucerne

6500

Ospedale San Giovanni, Bellinzona

6600

Ospedale La Carita, Locarno

8091

University Hospital Zurich, Zurich

8500

Kantonsspital Thurgau, Frauenfeld

9007

Kantonsspital St. Gallen, Sankt Gallen

14129

Evangelisches Krankenhaus Hubertus, Berlin

64297

Max Ratschow Klinik Darmstadt, Darmstadt

76307

Klinikum Karlsbad-Langensteinbach, Karlsbad

80337

University Hospital Munich, Munich

Unknown

Dr. Doris Schulte, Berlin

01307

University Hospital Dresden, Dresden

All Listed Sponsors
lead

Arteriogenesis Competence Network

OTHER

NCT00189618 - The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD) | Biotech Hunter | Biotech Hunter